7XG-22437-00004
3 vaccinations
2 coded responses
18 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Pfizer-BioNTech
- 2021-01-02
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, DiarrheaAdult check-in
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-16
-
2021-01-22
Dose 2 — Pfizer-BioNTech
- 2021-01-30
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
-
2021-04-23
Survey response — 3 months, dose 2MedDRA: Diarrhoea, Nausea — Feeling: Good · Be unable to workFree text: Nausea, diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-23
-
2021-10-14
Dose 3 — Pfizer-BioNTech
- 2022-01-24
-
2022-10-14
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
Free text
Release 7 — 3 months, dose 2
Symptoms: Nausea, diarrhea
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release